Capital Fund Management S.A. Nektar Therapeutics Put Options Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $162,610 - $239,714	-3,500 Reduced 17.33%	16,700 $1.02 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $703,000 - $1.59 Million	15,200 Added 304.0%	20,200 $986,000
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $287,000 - $542,200	5,000 New	5,000 $531,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.